More Stories

Informist, Friday, May 8, 2026

 

Please click here to read all liners published on this story

--Cholamandalam Fincl Jan-Mar consol net profit INR 6.87 bln 
--Cholamandalam Fincl FY26 consol PAT INR 24.41 bln vs INR 21.74 bln yr ago 
--Cholamandalam Fincl Jan-Mar consol total income INR 105.20 bln 
--Cholamandalam Fincl Jan-Mar consol PAT INR 6.87 bln vs INR 6.14 bln yr ago 
--Cholamandalam Fincl Q4 consol total income INR 105.20 bln vs INR 90.09 bln 
--Cholamandalam Fincl to pay INR 1.30 per share final dividend 
--Cholamandalam Fincl final dividend record date is Aug 7 
--Cholamandalam Fincl FY26 consol total income INR 395.8 bln vs INR 334.6 bln 
--Cholamandalam Fincl appoints Shyam Shankar as CFO from Jun 15 
--Cholamandalam Fincl CFO N Ganesh resigns from Jun 14 

 

By Durgesh Nandan
 

MUMBAI – Cholamandalam Financial Holdings Ltd. reported year-on-year growth in its consolidated net profit for the March quarter owing to a healthy rise in its total income. However, an increase in impairment for bad loans limited the rise of the investment company's bottom line. 

 

Cholamandalam Financial's consolidated profit after tax for the March quarter was INR 6.87 billion, up 12% on year and 9.8% sequentially. The company's total income for the quarter rose nearly 17% on year to INR 105.20 billion. Its interest income grew over 18% on year to INR 79.21 billion. The other income soared almost 60% to INR 1.53 billion. Premium ceded to reinsurers--a drag on the top line--declined to INR 5.12 billion from INR 7.10 billion in the year-ago quarter.

Impairment on financial instruments rose nearly 46% on year to INR 8.52 billion in the March quarter, though the number fell over 6% from Oct-Dec. The company's shares ended at INR 1,780.70 on the National Stock Exchnage, up 1.5% from Thursday. The holding company declared its earnings during market hours.

 

The consolidated impairment was up because of subsidiary Cholamanadalam Investment and Finance Co. Ltd.'s INR 2-billion management overlay during the March quarter, created to mitigate risks from the war in West Asia. With the sharp increase in provisions, the company's total expenses for the reporting quarter rose over 17% on year but only marginally on quarter to INR 83.80 billion.

 

In addition to the sharp rise in impairments, the company's insurance claims rose over 14% on year to INR 13.40 billion. Its employee benefit expenses rose nearly 16% on year to INR 12.17 billion. Other expenses grew by nearly 26% on year to 11.33 billion.

 

Cholamandalam MS General Insurance Co. Ltd., a subsidiary in the general insurance business, in which the company holds about 60% stake, reported a net loss of INR 50 million for the March quarter against a net profit of INR 1.18 billion for the year-ago period. The company posted a gross written premium of INR 91.10 billion in the financial year 2025-26 (Apr-Mar), up from INR 85.64 billion in FY25.

 

Cholamandalam MS Risk Services Ltd., a joint venture company in which Cholamandalam Financial holds 49.5% stake, reported a total income of INR 289.8 million for the March quarter, up from INR 247.9 million for the year-ago period. The net profit was INR 35.5 million, down slightly from INR 36.3 million.

 

For FY26, Cholamandalam Financial Holdings reported a consolidated net profit of INR 24.41 billion, up over 12% from FY25. The total income for the year was INR 395.76 billion, up more than 18%.

 

The board approved the appointment of Shyam Shankar to replace N. Ganesh as chief financial officer from Jun. 15. It also approved a final dividend of INR 1.30 per equity share for FY26 with Aug. 7 being the record date.  End

 

Edited by Rajeev Pai

 

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

 

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.

 

Informist Media Tel +91 (22) 6985-4000 

Send comments to feedback@informistmedia.com

 

© Informist Media Pvt. Ltd. 2026. All rights reserved.